12 Jan 2024

The annual J.P. Morgan Healthcare Conference is “the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.” (JPMorgan.com)

This year, we pulled the top headlines from Healthcare Marketing Daily (our complimentary newsletter for healthcare marketers!) to bring our readers up to speed on JPM 2024, which took place in San Francisco, California on January 8-11, 2024.

In case you missed it, check out the highlights below and sign up for Healthcare Marketing Daily to receive future industry insights directly to your inbox.

Conference Highlights

Clinical Research & Trials

Sanofi May Consider Potential of Next-Gen Weight Loss Drugs, Execs Say: Endpoints News

Novartis Has Been ‘Active’ In Neuroscience Business Development: FierceBiotech

Medical Devices

Hologic Has Become ‘Bigger, Faster, Stronger’ Through Strategic Acquisitions: FierceBiotech


Bluebird Bio CEO Defends Lyfgenia’s Pricing With Outcomes-Based Contracts: FiercePharma


Amazon, Omada Health Launches New Program Offering Virtual Benefits: Fierce Healthcare


Socially Determined, Uber Health To Collaborate On Health Analytics: Fierce Healthcare


Pfizer Among Biopharma Companies Emphasizing Renewal: Medical Marketing & Media

BMS Expects To Add 16 New Products By 2030, CEO Says: Reuters

Sanofi CEO Open-Minded To M&A, Reiterates Ambitions For ‘New’ CompanyEndpoints News 

Novo Nordisk ‘Just Getting Going’ In Obesity Drug Field, CEO Says: FiercePharma

Johnson & Johnson To Acquire ADC Specialist Ambrx Biopharma For $2 Billion: CNBC

AbbVie Confident It Will Retain Strong Botox Market Share Amid Rivals: Reuters

Biogen CEO Talks Leqembi Launch Progress At JPM: BioPharma Dive

Don’t forget to sign up for Healthcare Marketing Daily, follow us on LinkedIn, and return to this space for more industry insights like this!